2023 Prepped and Primed: Opyl (ASX:OPL) with CEO, Michelle Gallaher

Michelle Gallaher, CEO at Opyl, shares her outlook for 2023.

“We are right in the process now of signing Master Service Agreements with a number of the top 10 global pharmaceutical companies. […] Master service agreements are a ticket to play,” said Michelle Gallaher in the video.

“We are focusing our development and R&D effort for 2023. That’s opening up some more automation on the platform which will give us more passive income but also be able to scale.”

View the video on Stockhead: https://stockhead.com.au/stockhead-tv/2023-prepped-and-primed-opyl-asxopl-with-ceo-michelle-gallaher/